Name & Date of birth : Atieh Amouzegar / 2st September 1971
Current Address: Assistant Professor, Academic faculty member of Research Institute for Endocrine Sciences (RIES), Endocrine research center, Shahid Beheshti University of Medical Sciences. – Iran P.O.Box: 19395-4763
Current Phone: +982122432500
Office Phone: +982122432500
Permanent Address: Endocrine Research center, Research Institute for endocrine sciences, Shahid Beheshti University of Medical Sciences.– Iran P.O.Box: 19395-4763
Name of College/University:
Medical doctor. Iran University of Medical Sciences, Tehran Iran Year of Graduation: 1998
Specialty of Internal Medicine .Tehran University of medical science, Tehran Iran 2004
Sub specialty of endocrinology and metabolism Shahid Beheshti University of medical science,Tehran Iran 2007
Thesis Title: “day to day variation in urinary iodine in pregnant women resident of iodine sufficient area”
Honors of Awards:
Second rank of National Board of Endocrinology in 2007
Organization: Assistant professor, Faculty Member of Research Institute for endocrine sciences, Shahid Behesthi University of Medical Sciences Tehran Iran
Amouzegar A, Beigy M, Gharibzadeh S, Azizi F. Underestimation of Thyroid Dysfunction Risk Due to Regression Dilution Bias in a Long-Term Follow-Up: Tehran Thyroid Study (TTS). Horm Metab Res. 2014 Jun; 46(6):440-4.
Talaei B, Amouzegar A, Sahranavard S, Hedayati M, Mirmiran P, Azizi F. Effects of Cinnamon Consumption on Glycemic Indicators, Advanced Glycation End Products, and Antioxidant Status in Type 2 Diabetic Patients. Nutrients. 2017 Sep 8;9(9). pii: E991. doi: 10.3390/nu9090991
Azizi F, Amouzegar A. Controversies in Management of Hyperthyroidism during Pregnancy. Arch Iran Med. 2017 Oct; 20(10):657-658.
Mehran L, Khalili D, Yarahmadi S, Amouzegar A, Mojarrad M, Ajang N, Azizi F. Worldwide Recall Rate in Newborn Screening Programs for Congenital Hypothyroidism.. Int J Endocrinol Metab. 2017 Jun 25;15(3):e55451. doi: 10.5812/ijem.55451
Askari S, Abdi H, Ahmadi S, Bahadoran Z, Amouzegar A.Knowledge of Thyroid Disorders during Pregnancy among General Practitioners in Iran. Int J Endocrinol Metab. 2017 Jun 21;15(3):e55450.
Ghazi AA, Zadeh-Vakili A, Zarif Yeganeh M, Alamdari S, Amouzegar A, Khorsandi AA, Amirbaigloo A, Azizi F. Hereditary Vitamin D Resistant Rickets: Clinical, Laboratory, and Genetic Characteristics of 2 Iranian Siblings. Int J Endocrinol Metab. 2017 Jul 31;15(3):e12384.
Khamseh ME, Mohajeri Tehrani MR, Mousavi Z, Malek M, Imani M, Hoshangian Tehrani N, Ghorbani M, Akbari H, Sarvghadi F, Amouzegar A, Esfahanian F, Hashemi Madani N, Emami Z. Iran Pituitary Tumor Registry: Description of the Program and Initial Results. Arch Iran Med. 2017 Dec 31;20(12):746-751.
Tohidi M, Derakhshan A, Akbarpour S, Amouzegar A, Mehran L, Baghbani-Oskouei A, Azizi F, Hadaegh F. Thyroid Dysfunction States and Incident Cardiovascular Events: The Tehran Thyroid Study. Horm Metab Res. 2018 Jan;50(1):e1. doi: 10.1055/s-0043-123039.
Abdi H, Gharibzadeh S, Tasdighi E, Amouzegar A, Mehran L, Tohidi M, Azizi F.Associations Between Thyroid and Blood Pressure in Euthyroid Adults: A 9-Year Longitudinal Study. Horm Metab Res. 2018 Mar;50(3):236-241.
Abdi H, Amouzegar A, Tohidi M, Azizi F, Hadaegh F. Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS). Int J Endocrinol Metab. 2018 Oct 20 ;16(4 Suppl):e84769.
Parizadeh D, Momenan AA, Amouzegar A, Azizi F, Hadaegh F.Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018 Oct 31;16(4 Suppl):e84738.
Amouzegar A, Mehran L, Takyar M, Abdi H, Azizi F. Tehran Thyroid Study (TTS). Int J Endocrinol Metab. 2018 Oct 24; 16(4 Suppl):e84727.
Amiri P, Kazemian E, Mansouri-Tehrani MM, Khalili A, Amouzegar A. Does motivational interviewing improve the weight management process in adolescents? Protocol for a systematic review and meta-analysis. Syst Rev. 2018 Oct 30; 7(1):178.
Safoora Gharibzadeh,Mohammad Ali Mansournia,Abbas Rahimiforoushani,Ahad Alizadeh,Atieh Amouzegar,Kamran Mehrabani-Zeinabad, Kazem Mohammad. Comparing different propensity score estimation methods for estimating the marginal causal effect through standardization to propensity scores. Communications in Statistics: Simulation and Computation.2018; 47(4): 964-976.
Nodehi M, Ajami A, Izad M, Asgarian Omran H, Chahardoli R, Amouzegar A, Yekaninejad S, Hemmatabadi M, Azizi F, Esfahanian F, Mansouri F, Mazaheri Nezhad Fard R, Saboor-Yaraghi AA. Effects of vitamin D supplements on frequency of CD4+ T-cell subsets in women with Hashimoto's thyroiditis: a double-blind placebo-controlled study. Eur J Clin Nutr. 2019 Jan 29. doi: 10.1038/s41430-019-0395-z.
Mehran L, Khalili D, Yarahmadi Sو Delshad H, Mehrabi Y, Amouzegar A, Ajang N, Azizi F. Evaluation of the congenital hypothyroidism screening programme in Iran: a 3-year retrospective cohort study.Arch Dis Child Fetal Neonatal Ed. 2019 Mar;104(2):F176-F181. doi: 10.1136/archdischild-2017-313720.
Azizi F, Takyar M, Madreseh E, Amouzegar A. Treatment of Toxic Multinodular Goiter: Comparison of Radioiodine and Long-Term Methimazole Treatment. Thyroid. 2019 May;29(5):625-630.
Azizi F, Takyar M, Madreseh E, Amouzegar A. Long-term Methimazole Therapy in Juvenile Graves' Disease: A Randomized Trial. Pediatrics. 2019 May;143(5). pii: e20183034.
Chahardoli R, Saboor-Yaraghi AA, Amouzegar A, Khalili D, Vakili AZ, Azizi F. Can Supplementation with Vitamin D Modify Thyroid Autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and Thyroid Profile (T3, T4, TSH) in Hashimoto's Thyroiditis? A Double Blind, Randomized Clinical Trial. Horm Metab Res. 2019 May;51(5):296-301.
Ahi S, Amouzegar A, Gharibzadeh S, Delshad H, Tohidi M, Azizi F. Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study. PLoS One. 2019 May 16;14(5):e0216389.
Kazemian E, Akbari ME, Moradi N, Gharibzadeh S, Mondul AM, Jamshidi-Naeini Y, Khademolmele M, Zarins KR, Ghodoosi N, Amouzegar A, Davoodi SH, Rozek LS.Vitamin D Receptor Genetic Variation and Cancer Biomarkers among Breast Cancer Patients Supplemented with Vitamin D3: A Single-Arm Non-Randomized Before and After Trial.Nutrients. 2019 Jun 4;11(6). pii: E1264.
Keyhanian M, Sarvghadi F, Mehran L, Amouzegar A, Beigy M, Tohidi M, Azizi F. Long-Term Variations of Antithyroperoxidase Antibodies and its Clinical Significance. Horm Metab Res. 2019 Jun;51(6):347-352.
Mehran L, Yarahmadi S, Khalili D, Hedayati M, Amouzegar A, Mousapour P, Ajang N, Azizi F. Audit of the Congenital Hypothyroidism Screening Program in 15 Provinces of Iran. Arch Iran Med. 2019 Jun 1;22(6):310-317
Amiri P, Mohammadzadeh-Naziri K, Abbasi B, Cheraghi L, Jalali-Farahani S, Momenan AA, Amouzegar A, Hadaegh F, Azizi F. Smoking habits and incidence of cardiovascular diseases in men and women: findings of a 12 year follow up among an urban Eastern-Mediterranean population. BMC Public Health. 2019 Aug 5;19(1):1042. doi: 10.1186/s12889-019-7390-0.
Kazemian E, Amouzegar A, Akbari ME, Moradi N, Gharibzadeh S, Jamshidi-Naeini Y, Khademolmele M, As-Habi A, Davoodi SH. Vitamin D receptor gene polymorphisms affecting changes in visceral fat, waist circumference and lipid profile in breast cancer survivors supplemented with vitamin D3. Lipids Health Dis. 2019 Aug 9;18(1):161. doi: 10.1186/s12944-019-1100-x.
Azizi F, Amouzegar A, Tohidi M, Hedayati M, Cheraghi L, Mehrabi Y. Systemic Thyroid Hormone Status in Treated Graves' Disease. Int J Endocrinol Metab. 2019 Oct 12;17(4):e95385. doi: 10.5812/ijem.95385. eCollection 2019 Oct.
Azizi F, Amouzegar A, Tohidi M, Hedayati M, Khalili D, Cheraghi L, Mehrabi Y, Takyar M. Increased remission rates after long-term methimazole therapy in patients with Graves' disease: Results of a randomized clinical trial. Thyroid. 2019 Sep;29(9):1192-1200. doi: 10.1089/thy.2019.0180. Epub 2019 Aug 28.
Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, Asghari G, Parizadeh D, Montazeri SA, Lotfaliany M, Takyar F, Khalili D. Metabolic health in the Middle East and north Africa.
Kazemian E, Amouzegar A, Akbari ME, Moradi N, Gharibzadeh S, Jamshidi-Naeini Y, Khademolmele M, As'habi A, Davoodi SH.Correction to: Vitamin D receptor gene polymorphisms affecting changes in visceral fat, waist circumference and lipid profile in breast cancer survivors supplemented with vitamin D3.
Lipids Health Dis. 2019 Sep 14;18(1):174. doi: 10.1186/s12944-019-1110-8.
Elham Kazemin, Yasaman Jamshidi-naeini, Mohammad Esmaeil Akbari, Nariman Moradi, Safoora Gharibzadeh, Atieh Amouzegar, Alison Mondul, Maryam Khademolmele, Nasim Ghodoosi, Katie R Zarins, Sayed Hossein Davoodi, Laura Rozek. Interaction Effects of Vitamin D Receptor Polymorphisms and Vitamin D3 Supplementation on Plasma Oxidative Stress and Apoptotic Biomarkers Among Breast Cancer Survivors (P05-027-19). Curr Dev Nutr. 2019 Jun; 3(Suppl 1): nzz030.P05-027-19. Published online 2019 Jun 13. doi: 10.1093/cdn/nzz030.P05-027-19.
Sara Bahri , Fahimeh Ramezani Tehrani , Atieh Amouzgar , Maryam Rahmati , Maryam Tohidi , Maryam Vasheghani , Fereidoun Azizi. Overtime trend of thyroid hormones and thyroid autoimmunity and ovarian reserve: A longitudinal population study with a 12-year follow up. BMC Endocrine Disorders, 2019; 19(1): 47.
Mehran L, Amouzegar A, Azizi F. Thyroid disease and the metabolic syndrome. Curr Opin Endocrinol Diabetes Obes. 2019 Oct;26(5):256-265. doi: 10.1097/MED.0000000000000500.
Kadkhodazadeh H, Amouzegar A, Mehran L, Gharibzadeh S, Azizi F, Tohidi M. Smoking status and changes in thyroid-stimulating hormone and free thyroxine levels during a decade of follow-up: The Tehran thyroid study. Caspian J Intern Med. 2020 Winter;11(1):47-52. doi: 10.22088/cjim.11.1.47.
Kazemian E, Akbari ME, Moradi N, Gharibzadeh S, Amouzegar A, Jamshidi-Naeini Y, Mondul AM, Khademolmele M, Ghodoosi N, Zarins KR, Shateri Z, Davoodi SH, Rozek LS. Effect of vitamin D receptor polymorphisms on plasma oxidative stress and apoptotic biomarkers among breast cancer survivors supplemented vitamin D3. 2020; European journal of cancer prevention, 29(5): 433-444.
Takyar M, Rahmani M, Amouzegar A, Madreseh E, Tohidi M, Mehran L, Azizi F. Parity and incidence of thyroid autoimmunity a population-based study Tehran thyroid study (TTS).Thyroid. 2020 Mar 11. doi: 10.1089/thy.2019.0440.
Isolated Hypothyroxinemia in Iranian Pregnant Women, the Role of Iodine Deficiency: A Population-Based Cross-Sectional Study. Etemadi A, Amouzegar A, Mehran L, Tohidi M, Azizi F, Moradi K, Delshad H. Thyroid. 2020 Feb;30(2):262-269.
Maryam Tohidi, Aidin Baghbani-Oskouei, Atieh Amouzegar, Ladan Mehran, Fereidoun Azizi, Farzad Hadaegh. Serum Thyroid Peroxidase Antibody Level and Incident Hypertension in Iranian Men: A Suggestion for the Role of Thyroid Autoimmunity. Endocr Metab Immune Disord Drug Targets. 20(10), 2020.1711-1718(8)
AmouzegarA, Ordokhani A ,Azizi F. Variation of Urinary Iodine Concentration Within a Month During the First Trimester of Pregnancy in Tehran an Iodine- Repleted Area and Comparison to Non-Pregnant Women. Vol 9 No.1 June 2007. Iranian Journal of Endocrinology & Metabolism
Sabet Z, Amouzegar A, Hedayati M, Azizi F.Predicting the Metabolic Syndrome According to Serum Total Testosterone, Free Testosterone Index and SHBG in Males Aged Over 20 Years: Tehran Lipid and Glucose (TLGS). Vol 11, No.4, November 2009. Iranian Journal of Endocrinology & Metabolism.
Delshad H, Amouzegar A, Salehi F, Azizkhani N, Delshad M, Azizi F. Goiter and Urinary Iodine Excretion Survey of Schoolchildren in Qazvin Provine: Results of 17 Years Universal Salt Iodization in Iran (2007). Vol 13 No.3 September 2011. Iranian Journal of Endocrinology & Metabolism.
Hossein Delshad, Atieh Amouzegar, Saeed Sadeghyan Sharif , Ladan Mehran , Farid Ordokhani
Feridoun Azizi. Goiter monitoring of schoolchildren in Kermanshah province; 17 years after salt iodization program. Journal of Kermanshah University of Medical Sciences. 2011;15(3)220-226
Bahadoran Z , Golzarand M , Mirmiran P , Amouzgar A , Azizi F .Association Between Dietary Phytochemical Index and Occurrence of Metabolic Syndrome and Its Risk Factors (Among Tehranian Adults): Tehran Lipid and Glucose Study. Vol 14 No.4 November 2012. Iranian Journal of Endocrinology and Metabolism
Faam B , Amouzegar A , Delshad M , Ghanbarian A , Hossein Panah F , Azizi F. Leisure-Time Physical Activity and its Association with Metabolic Risk Factors in Tehranian Adults: TLGS. Vol 14 No.4 November 2012. Iranian Journal of Endocrinology & Metabolism.
Delshad H, Amouzgar A, Mirmiran P, Azizi F. Eighteen Years of Universal Salt Iodization in Iran; The Fourth National Survey of Goiter Prevalence and Urinary Iodine Excretion of Schoolchildren (2007-2008). Vol 15 No.1 May 2013. Iranian Journal of Endocrinology & Metabolism.
Azizi F , Delshad H , Amouzegar A , Mehran L , Mirmiran P , Sheikholeslam R. Marked Reduction in Goiter Prevalence and Eventual Normalization of Urinary Iodine Concentrations in Iranian Schoolchildren, 10 Years After Universal Salt Iodination
L Mehran, M Delshad, A Amouzegar, Hasheminia M, H Delshad, F Azizi. Does serum TSH Thyrotropin within normal range in associated with body mass index? Iranian Journal of Endocrinology & Metabolism.
L Mehran, G Amirshekari, A Amouzegar, M Hasheminia, H Delshad, F Azizi. Smoking, thyroid function and thyroxine index antibody. Iranian Journal of Endocrinology & Metabolism.
Ramezani Tehrani F , Zadeh Vakili A, Hashemi S , Amuzegar A , Azizi F.Associations Between Hormonal Profiles of Urban Iranian Women of Reproductive age: A Community Based Study of Four Provinces. Iranian Journal of Endocrinology & Metabolism.Vol 14 No.1 May 2012.
Azizi F, Delshad H, Amouzegar A, Mehran L, Mirmiran P, Zahedi Asl S. Prevention of Iodine-deficiency Induced Goiter and Brain Damage in the Islamic Republic of Iran. Iranian Journal of Endocrinology and Metabolism. Vol 15 No.5 January 2014
Azizi F, Delshad H, Amouzegar A, Mehran L, Mirmiran P, Sheikholeslam R, Naghavi M, Ordookhani A, Hedayati M, Padyab M. Marked Reduction in Goiter Prevalence and Eventual Normalization of Urinary Iodine Concentrations in Iranian Schoolchildren, 10 Years After Universal Salt Iodination (Third National Survey of Iodine Deficiency Disorders 2000)
Sadatamini M, Delshad H, Amouzegar A, Tohidi M, Azizi F. The Incidence of Thyroid Dysfunctions in Patients with Type 2 Diabetes: a Twelve-year Follow-up of the Tehran Lipid and Glucose Study. Iranian Journal of Endocrinology and Metabolism. Vol 17 No.1 April-May 2015.
HamzaviZarghani N,Ghofranipour F, Amiri P, Amouzegar A, Nazeri P, Hedayati M, Mirmiran P, Azizi F . Iodine Intake Knowledge, Attitude and Practice in Pregnant Women and its Relation to Iodine Status during Pregnancy. Iranian Journal of Endocrinology and Metabolism. Vol 17 No.6 February-March 2016.
Clinical guidelines for the diagnosis and treatment of thyroid disorders during pregnancy and postpartum (Iran Endocrine Society). IJEM Vol 18, 3 (serial number 87),Aug –Sep 2016 (FARSI version for Iranian clinicians).
13th world congress of Gynecological Endocrinology, February 28-March 2, 2008. Florence Italy. What are the risk factors of premature ovarian failure and early menopause among women in Tehran lipid glucose study (TLGS)? A.Amouzegar, F,Ramezani
8thInternational congress of Endocrine disorders and 2nd Arab –Iran Congress of Endocrinology and Diabetes, October 2728 2009 Tehran Iran.Adrenal incidentaloma.A Amouzegar
8thInternational congress of Endocrine disorders and 2nd Arab –Iran Congress of Endocrinology and Diabetes, October 2728 2009 Tehran Iran. Continuous adequate iodine nutrition in I.R.Iran ;The 2007 goiter and urinary iodine excretion survey in school children.A Amouzegar
The first national Congress of Endocrine and Metabolism Update.31 Oct-1 Nov 2007 Isfahan, Iran. Tumor induced hypercalcemia , presentation of an unusual case and review of literature.Mir Saeed Ghazi Ali.Amouzegar Atieh
The first national Congress of Endocrine and Metabolism Update.31 Oct-1 Nov 2007 Isfahan, Iran. Variation of urinary iodine Concentration within a month during the first trimester of pregnancy in Tehran an iodine-depleted area.A.Amouzegar
17th congress of Iranian Society for Reproductive Medicine. 11-13 march 2011 tehran.I.R.Iran.Endocrine and male infertility.
6th Annual world Congress on Insulin Resistance, 25-27 Sep, 2008, California USA. Serum level of Triglycerides and waist circumference as the markers of cardiovascular risk factors in females (TLGS). A.Amouzegar ,M Solaty,Z Sabet,F Azizi
14th International thyroid congress ,11-16 Sept 2010 , Paris France, Thyroid dysfunction and age: Tehran Lipid and Glucose Study (TLGS) Amouzegar A, Delshad H, Azizi F
10th International Congress of Endocrine Disorders:22-24 Oct,2014:
Socio-Behavioral and Reproductive Predictors of Onset of Menopause in Women with and without Metabolic Syndrome: Tehran Lipid and Glucose Study
Prevalence of Subclinical Hypothyroidism in Chronic Kidney Disease: Tehran Thyroid Study
Prevalence of Hypothyroidism in Patients with Dyslipidemia: Tehran Thyroid Study (TTS)
The Predictive Value of Metabolic Syndrome for Cardiovascular and All-Cause Mortality According to Different Definitions in the Middle East Caucasian Residents: Tehran Lipid and Glucose Study
Association Between Serum Nitric Oxide Metabolites and Thyroid Hormones in a General Population: Tehran Lipid and Glucose Study
Differentiate Thyroid Cancers from Benign Nodules Using Thyroid Hormones and TSH Levels in Iranian Population
38th Annual Meeting of the European Thyroid Association, Spain, 2014:
Thyroid disorders and lipid levels in a community based study: Tehran Thyroid study (TTS)